Bacterial Vaginosis in HIV-Positive and HIV-Negative Women

December 2016

Research teams in the U.S. have been studying the health issues of women with or at high risk for HIV infection as part of a project called the Women's Interagency HIV Study (WIHS, pronounced wise). Analyses of WIHS have produced many useful reports over the years. A recent WIHS analysis has focused on the diagnosis of BV in 3,730 women (964 without HIV and 2,766 with HIV). These women were monitored for about 11 years. Over the course of the study, 55% of HIV-negative and 47% of HIV-positive women were diagnosed with BV; this difference was statistically significant.  The researchers also found that 43% of women who were treated for BV had a recurrence within a year. This was not affected by HIV status.

The WIHS researchers noted that women in their study were "dissatisfied with current therapies" and they encouraged doctors caring for women with BV to consider the following possibilities:

  • home screening of BV (sending samples of vaginal fluid to a lab)
  • use of probiotics to help reduce the recurrence of BV
  • provision of antibiotics in advance of a recurrence of BV so that patients can "use when symptoms recur to  minimize delay arising from the need for a [visit to the doctor]."


Massad LS, Evans CT, Kang R, et al. Correlates of bacterial vaginosis over long-term follow-up: Impact of human immunodeficiency virus infection. AIDS Research and Human Retroviruses. 2016; in press.

Related Stories

Background on Bacterial Vaginosis in Women
Bacterial Vaginosis -- Some Research Issues

This article was provided by Canadian AIDS Treatment Information Exchange. It is a part of the publication TreatmentUpdate. Visit CATIE's Web site to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.